Englewood Health laboratory

Open Clinical Trials

Englewood Health laboratory

Englewood Hospital’s physician-investigators are currently recruiting research subjects for participation in several clinical trials across various departments.

Anesthesiology

REGAIN: A Randomized Controlled Trial of Regional versus General Anesthesia for Promoting Independence After Hip Fracture

Principal Investigator: Gregg Lobel, MD
Coordinator: Hana Badivuku
Phone: 201-894-3163
NCT #: 02057505
Englewood Health IRB #: E-15-637
More Information (clinicaltrials.gov)

Cardiology

Champion AF: WATCHMAN FLX versus NOAC for Embolic Protection in the Management of Patients with Non-Valvular Atrial Fibrillation

Principal Investigator: Grant Simons, MD
Coordinator: Hana Badivuku
Phone: 201-894-3603
NCT #: 04394546
Englewood Health IRB #: E-20-839
More Information (clinicaltrials.gov)

PROTECTED TAVR: Stroke PROTECTion with SEntinel During Transcatheter Aortic Valve Replacement

Principal Investigator: Joseph De Gregorio, MD
Coordinator: Beatriz Sosa
Phone: 201-608-2663
NCT #: 04149535
Englewood Health IRB #: E-20-812
More Information (clinicaltrials.gov)

Gastroenterology

A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects with Moderate to Severe Active Ulcerative Colitis

Principal Investigator: Mark Sapienza, MD
Coordinator: Hana Badivuku
Phone: 201-894-3603
NCT #: 04504383
Englewood Health IRB #: E-20-824
More Information (clinicaltrials.gov)

Gastroenterology / C Diff

Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI)

Principal Investigator: Marc Fiorillo, MD
Coordinator: Hana Badivuku
Phone: 201-894-3163
NCT #: 01942447
Englewood Health IRB #: E-13-507
More Information (clinicaltrials.gov)

Gynecology

A randomized controlled trial to evaluate the efficacy of acupuncture versus aromatherapy as treatments to lessen nausea and vomiting associated with Adriamycin and Cytoxan

Principal Investigator: Tracy Scheller, MD
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 04116697
Englewood Health IRB #: E-19-773
More Information (clinicaltrials.gov)

NICU

A Pilot Study to Look at the Use of a Stabilizing (Weighted) Pacifier vs. the Use of a Traditional Non-Stabilizing (Weighted) Pacifier to Improve Infant Comfort, Caregiver Satisfaction, and Safety During Non-Nutritive Sucking

Principal Investigator: Mary De Ritter, MSN, RN, CNL
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 04095702
Englewood Health IRB #: E-19-782
More Information (clinicaltrials.gov)

Oncology

EAZ171: Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04001829
Englewood Health IRB #: E-19-794
More Information (clinicaltrials.gov)

Oncology / Bladder Cancer

A phase II study of dose-dense gemcitabine plus cisplatin (ddGC) in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterios DNA damage response (DDR) gene alterations

Principal Investigator: Brian Kim, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03609216
Englewood Health IRB #: E-18-748
More Information (clinicaltrials.gov)

Oncology / Breast Cancer

A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Principal Investigator: David Dubin, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 01901094
Englewood Health IRB #: E-18-749
More Information (clinicaltrials.gov)

A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02750826
Englewood Health IRB #: E-16-663
More Information (clinicaltrials.gov)

B-51: Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

Principal Investigator: David Dubin, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 01872975
Englewood Health IRB #: E-16-651
More Information (clinicaltrials.gov)

COMET: Comparison Of Operative To Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial

Principal Investigator: Steven Brower, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02926911
Englewood Health IRB #: E-17-710
More Information (clinicaltrials.gov)

Oncology / Colon Cancer

A021502: Randomized Trial of Standard Chemotherapy alone or combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer with Deficient DNA Mismatch (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02912559
Englewood Health IRB #: E-18-752
More Information (clinicaltrials.gov)

A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04094688
Englewood Health IRB #: E-19-792
More Information (clinicaltrials.gov)

Oncology / Colorectal Cancer

A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination with or without Atezolizumab or Atezolizumab Monotherapy in First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02997228
Englewood Health IRB #: E-18-753
More Information (clinicaltrials.gov)

Oncology / Gastric Cancer

IMIGASTRIC II: Prospective, observational, multicenter study on minimally invasive gastrectomy for gastric cancer: robotic, laparoscopic and open surgery compared on operative and follow-up outcomes

Principal Investigator: Steven Brower, MD
Coordinator: Anna Feiler
Phone: 201-894-3917
NCT #: 02751086
Englewood Health IRB #: E-16-673
More Information (clinicaltrials.gov)

Oncology / Neuroendocrine

A021602 Advanced Neuroendocrine Tumors: “A021602, Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus (CABINET)

Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03375320
Englewood Health IRB #: E-18-754
More Information (clinicaltrials.gov)

Oncology / Renal Cancer

EA8143: A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

Principal Investigator: Maz Ganat, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03055013
Englewood Health IRB #: E-19-784
More Information (clinicaltrials.gov)

Vascular Surgery

VIVID: Venous stent for the Iliofemoral Vein Investigational clinical trial using DUO™ Venous Stent System

Principal Investigator: Steven Elias, MD
Coordinator: Hana Badivuku
Phone: 201-894-3603
NCT #: 04580160
Englewood Health IRB #: E-20-838
More Information (clinicaltrials.gov)

Share This